27877221|t|The Impact of Diabetes on the Risk of Prostate Cancer Development according to Body Mass Index: A 10-year Nationwide Cohort Study
27877221|a|Purpose: We examined the association between obesity and prostate cancer both with and without diabetic patients included in the analysis using nationally representative data of the Korean population from the National Health Insurance System (NHIS). Materials and Methods: Of the 424,712 participants who underwent health examinations in 2002-2008, 139,519 men ≥40 years old and without prostate cancer were followed from the beginning of 2002 to the end of 2012. Multivariate adjusted Cox regression analysis was conducted to examine the hazard ratio (HR) and 95% confidence interval (CI) for the association between prostate cancer and body mass index (BMI) both with and without diabetes. Results: The HR for prostate cancer according to the existence of diabetes was stratified by BMI in both age - and multivariable-adjusted models. In the population without diabetes, the HR for prostate cancer significantly increased as BMI increased beyond the reference range in a model adjusted for age and multiple variables; however, the increase in the HR was small. In the population with diabetes, the HR for prostate cancer significantly increased as BMI increased from < 18.5 kg/m(2) to within the reference range (18.5 to 22.9) in the multivariable-adjusted model. In addition, a marked decrease in HR in the population with BMI of < 18.5 kg/m(2) was seen compared to the reference or higher BMI population. Conclusion: This population -based study shows the evidence of association between obesity and development of prostate cancer, and the risk increases vary according to the change of BMI category and the existence of diabetes.
27877221	4	13	Impact of	T080	C4049986
27877221	14	22	Diabetes	T047	C0011847
27877221	30	34	Risk	T078	C0035647
27877221	38	53	Prostate Cancer	T191	C0376358
27877221	54	65	Development	T169	C1527148
27877221	79	94	Body Mass Index	T201	C1305855
27877221	117	129	Cohort Study	T081	C0009247
27877221	175	182	obesity	T047	C0028754
27877221	187	202	prostate cancer	T191	C0376358
27877221	217	224	without	T080	C0332288
27877221	225	233	diabetic	T047	C0011847
27877221	234	242	patients	T101	C0030705
27877221	300	304	data	T078	C1511726
27877221	312	329	Korean population	T098	C1556095
27877221	339	371	National Health Insurance System	T058	C0027452
27877221	373	377	NHIS	T058	C0027452
27877221	418	430	participants	T098	C0679646
27877221	445	464	health examinations	T061	C0260135
27877221	487	504	men ≥40 years old	T098	C0025266
27877221	509	516	without	T080	C0332288
27877221	517	532	prostate cancer	T191	C0376358
27877221	594	615	Multivariate adjusted	T081	C0026777
27877221	616	639	Cox regression analysis	T081,T170	C0010235
27877221	669	681	hazard ratio	T081	C2985465
27877221	683	685	HR	T081	C2985465
27877221	695	714	confidence interval	T081	C0009667
27877221	716	718	CI	T081	C0009667
27877221	748	763	prostate cancer	T191	C0376358
27877221	768	783	body mass index	T201	C1305855
27877221	785	788	BMI	T201	C1305855
27877221	804	811	without	T080	C0332288
27877221	812	820	diabetes	T047	C0011847
27877221	835	837	HR	T081	C2985465
27877221	842	857	prostate cancer	T191	C0376358
27877221	888	896	diabetes	T047	C0011847
27877221	901	911	stratified	T080	C0205363
27877221	915	918	BMI	T201	C1305855
27877221	927	930	age	T032	C0001779
27877221	937	966	multivariable-adjusted models	T081	C0026777
27877221	975	985	population	T098	C1257890
27877221	986	993	without	T080	C0332288
27877221	994	1002	diabetes	T047	C0011847
27877221	1008	1010	HR	T081	C2985465
27877221	1015	1030	prostate cancer	T191	C0376358
27877221	1031	1054	significantly increased	T081	C0205217
27877221	1058	1061	BMI	T201	C1305855
27877221	1104	1149	model adjusted for age and multiple variables	T081	C0026777
27877221	1180	1182	HR	T081	C2985465
27877221	1201	1211	population	T098	C1257890
27877221	1217	1225	diabetes	T047	C0011847
27877221	1231	1233	HR	T081	C2985465
27877221	1238	1253	prostate cancer	T191	C0376358
27877221	1254	1277	significantly increased	T081	C0205217
27877221	1281	1284	BMI	T201	C1305855
27877221	1367	1395	multivariable-adjusted model	T081	C0026777
27877221	1412	1427	marked decrease	T081	C0547047
27877221	1431	1433	HR	T081	C2985465
27877221	1441	1451	population	T098	C1257890
27877221	1457	1460	BMI	T201	C1305855
27877221	1524	1527	BMI	T201	C1305855
27877221	1528	1538	population	T098	C1257890
27877221	1557	1567	population	T098	C1257890
27877221	1623	1630	obesity	T047	C0028754
27877221	1635	1646	development	T169	C1527148
27877221	1650	1665	prostate cancer	T191	C0376358
27877221	1675	1689	risk increases	T033	C0332167
27877221	1722	1725	BMI	T201	C1305855
27877221	1756	1764	diabetes	T047	C0011847